The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Hepatic Oncology
(Jun 2020)
HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
Devis Pascut,
Muhammad Yogi Pratama,
Claudio Tiribelli
Affiliations
Devis Pascut
1Fondazione Italiana Fegato – ONLUS, Liver Research Center, AREA Science Park, ss14, Km163.5, Basovizza, 34149 Trieste, Italy
Muhammad Yogi Pratama
1Fondazione Italiana Fegato – ONLUS, Liver Research Center, AREA Science Park, ss14, Km163.5, Basovizza, 34149 Trieste, Italy
Claudio Tiribelli
1Fondazione Italiana Fegato – ONLUS, Liver Research Center, AREA Science Park, ss14, Km163.5, Basovizza, 34149 Trieste, Italy
DOI
https://doi.org/10.2217/hep-2020-0010
Journal volume & issue
Vol. 7, no. 2
Abstract
Read online
No abstracts available.
Keywords
biomarkers
DAA
direct-acting antiviral
HCC
HCV
WeChat QR code
Close